DexCom, Inc. DXCM recently announced the FDA clearance for its 15-day wear G7 Continuous Glucose Monitoring (CGM) system, the ...

The FDA has cleared the Dexcom G7 15 Day continuous glucose monitoring system for individuals 18 years and older with diabetes.

In a head-to-head study, three continuous glucose monitoring systems showed different measurements in the same person, which ...

Dexcom has announced that the U.S. Food and Drug Administration has cleared its G7 15 Day Continuous Glucose Monitoring ...

SAN DIEGO – Dexcom is bringing back Dexcom U, a name, image and license program for college athletes with diabetes.

This uptick coincides with the company's announcement of FDA clearance for the Dexcom G7 Continuous Glucose Monitoring System, marking a significant advancement in diabetes management ...

DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, announced today the return of Dexcom U – its one-of-a-kind Name, Image and Likeness ...

The role of Continuous Glucose Monitoring (CGM) system like Dexcom G7 in Nick's diabetes journey Nick’s message also highlighted the Dexcom G7, a continuous glucose monitoring (CGM) system that ...

Dexcom U athletes will also receive access to Dexcom CGM, exclusive events and opportunities and a network of other collegiate and pro athletes – including mentors like Seattle Sounders forward ...